Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study

NCT02470208 is registered in ClinicalTrials.gov with Oxford Immunotec as lead sponsor.

NCT NCT02470208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02470208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study
Lead sponsor
Oxford Immunotec
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
July 31, 2017
Enrollment
250 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

infection